MedTrace Logo

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

NCT07632742 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-06-08

No results posted yet for this study

Summary

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Conditions

  • Enlarged Prostate (BPH)
  • Benign Prostatic Hyperplasia

Interventions

DEVICE

Magneto 150 holmium laser

The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser

DEVICE

Moses 2.0 holmium laser

The HoLEP procedure will be performed using the Moses 2.0 holmium laser

Sponsors & Collaborators

Principal Investigators

  • Perry Xu, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2028-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07632742 on ClinicalTrials.gov